Figure 4.
Protein patterns that classify and predict outcome in lung cancer. (A) A profile of protein abundance measured by mass spectrometry that was selected to distinguish samples of primary non-small-cell lung carcinoma (NSCLC) from normal lung. Reprinted with permission from Elsevier © 2003, Yanagisawa et al. 2003. (B) Kaplan Meier survival analysis of NSCLC patients stratified based on proteomic profiles. Reprinted with permission from Elsevier © 2003, Yanagisawa et al. 2003.
